The Food and Drug Administration (FDA) was dangerously slow to respond to multiple complaints about conditions at an Abbott Nutrition facility that contributed to a nationwide infant formula shortage in 2022, according to a government watchdog report. FDA did not have adequate — and in some cases completely lacked — policies and procedures to identify risks to infant formula and then respond to those risks effectively, the report from the Department of Health and Human Services’ Office of Inspector General (OIG) found. For instance, the agency took more than 15 months to act on a whistleblower complaint about dangerous conditions at the Abbott plant that was first filed in Februar
Hence then, the article about fda took 15 months to act on infant formula whistleblower complaint audit says was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA took 15 months to act on infant formula whistleblower complaint, audit says )